While previous reports have described challenges in managing CML in patients with other thrombophilic conditions, such as factor V Leiden or antiphospholipid syndrome, the coexistence of protein S deficiency presents unique therapeutic considerations. Here, PROS1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.